Literature DB >> 16409144

West Nile virus: epidemiology and clinical features of an emerging epidemic in the United States.

Edward B Hayes1, Duane J Gubler.   

Abstract

West Nile virus (WNV) was first detected in North America in 1999 during an outbreak of encephalitis in New York City. Since then the virus has spread across North America and into Canada, Latin America, and the Caribbean. The largest epidemics of neuroinvasive WNV disease ever reported occurred in the United States in 2002 and 2003. This paper reviews new information on the epidemiology and clinical aspects of WNV disease derived from greatly expanded surveillance and research on WNV during the past six years.

Entities:  

Mesh:

Year:  2006        PMID: 16409144     DOI: 10.1146/annurev.med.57.121304.131418

Source DB:  PubMed          Journal:  Annu Rev Med        ISSN: 0066-4219            Impact factor:   13.739


  130 in total

Review 1.  The role of chemokines in the pathogenesis of neurotropic flaviviruses.

Authors:  Susana V Bardina; Jean K Lim
Journal:  Immunol Res       Date:  2012-12       Impact factor: 2.829

2.  Identification of multiple RIG-I-specific pathogen associated molecular patterns within the West Nile virus genome and antigenome.

Authors:  Jennifer German Shipley; Rianna Vandergaast; Lu Deng; Roy A Mariuzza; Brenda L Fredericksen
Journal:  Virology       Date:  2012-07-07       Impact factor: 3.616

Review 3.  Current trends in West Nile virus vaccine development.

Authors:  Ian J Amanna; Mark K Slifka
Journal:  Expert Rev Vaccines       Date:  2014-04-01       Impact factor: 5.217

4.  Crystal structure of west nile virus envelope glycoprotein reveals viral surface epitopes.

Authors:  Ryuta Kanai; Kalipada Kar; Karen Anthony; L Hannah Gould; Michel Ledizet; Erol Fikrig; Wayne A Marasco; Raymond A Koski; Yorgo Modis
Journal:  J Virol       Date:  2006-08-30       Impact factor: 5.103

5.  Chimeric vaccine composed of viral peptide and mammalian heat-shock protein 60 peptide protects against West Nile virus challenge.

Authors:  Orly Gershoni-Yahalom; Shimon Landes; Smadar Kleiman-Shoval; David Ben-Nathan; Michal Kam; Bat-El Lachmi; Yevgeny Khinich; Michael Simanov; Itzhak Samina; Anat Eitan; Irun R Cohen; Bracha Rager-Zisman; Angel Porgador
Journal:  Immunology       Date:  2010-03-16       Impact factor: 7.397

6.  Anti-inflammatory activity of intravenous immunoglobulins protects against West Nile virus encephalitis.

Authors:  Ruchi Srivastava; Chandran Ramakrishna; Edouard Cantin
Journal:  J Gen Virol       Date:  2015-02-09       Impact factor: 3.891

Review 7.  Current status of veterinary vaccines.

Authors:  Els N T Meeusen; John Walker; Andrew Peters; Paul-Pierre Pastoret; Gregers Jungersen
Journal:  Clin Microbiol Rev       Date:  2007-07       Impact factor: 26.132

8.  West nile virus.

Authors:  Georg Pauli; Ursula Bauerfeind; Johannes Blümel; Reinhard Burger; Christian Drosten; Albrecht Gröner; Lutz Gürtler; Margarethe Heiden; Martin Hildebrandt; Bernd Jansen; Thomas Montag-Lessing; Ruth Offergeld; Rainer Seitz; Uwe Schlenkrich; Volkmar Schottstedt; Johanna Strobel; Hannelore Willkommen
Journal:  Transfus Med Hemother       Date:  2013-07-04       Impact factor: 3.747

9.  West Nile Virus fidelity modulates the capacity for host cycling and adaptation.

Authors:  Haley S Caldwell; Kiet Ngo; Janice D Pata; Laura D Kramer; Alexander T Ciota
Journal:  J Gen Virol       Date:  2020-02-18       Impact factor: 3.891

10.  Oral administration of active hexose correlated compound enhances host resistance to West Nile encephalitis in mice.

Authors:  Shuhui Wang; Thomas Welte; Hao Fang; Gwong-Jen J Chang; Willi K Born; Rebecca L O'Brien; Buxiang Sun; Hajime Fujii; Ken-ichi Kosuna; Tian Wang
Journal:  J Nutr       Date:  2009-01-13       Impact factor: 4.798

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.